Close

Halozyme Therapeutics, Inc. (HALO) VP, CCO Shaffer Resigns

April 3, 2014 4:18 PM EDT Send to a Friend
James P. Shaffer, Vice President and Chief Commercial Officer of Halozyme Therapeutics, Inc. (Nasdaq: HALO), resigned from the Company effective ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login